Goldman portfolio of hedge fund favorites is trouncing the market this year
While the S & P 500 is trading close to its all-time high, a group of favored stocks among hedge funds is soaring even higher,...
Category : Global Market Trends
Warren Buffett’s eagerly anticipated annual letter lands Saturday. Here’s what to expect
Warren Buffett is about to address shareholders and countless admirers following a series of market-moving events — a fresh trade war, devastating wildfires as well...
Deutsche Bank is a rare Wall Street bank cautious on Nvidia before earnings
Ahead of Nvidia ‘s highly-anticipated quarterly earnings release next Wednesday, Deutsche Bank is a rare Wall Street bank that’s staying on the sidelines in failing...
Friday’s biggest Wall Street calls like Nvidia
Here are Friday’s biggest calls on Wall Street: Roth MKM initiates Quanta Services as buy The firm said the infrastructure company is best positioned for...
HSBC upgrades Unity shares after earnings beat, calls for more than 20% upside ahead
Unity Software shares may have even more room to run after its recent post-earnings gain, according to HSBC. The firm upgraded the stock to buy...
Rivian shares are sliding after earnings. Here’s where analysts stand
Analysts were standing to the sidelines following Rivian Automotive’s latest quarterly results , as they see a tough growth path ahead for the automaker. Rivian...
JPMorgan upgrades this Singapore-based ride-sharing stock, sees strong earnings ahead
Ride-sharing and food delivery application developer Grab Holdings could be poised for more upside following its latest earnings outlook, according to JPMorgan. The firm upgraded...
GameStop CEO Ryan Cohen hikes his personal stake in Alibaba to $1 billion, the WSJ says
GameStop Chairman Ryan Cohen. CNBC GameStop CEO and billionaire investor Ryan Cohen has increased his personal stake in Chinese e-commerce giant Alibaba to roughly 7...
Investors are flocking to this higher-yielding tax-free corner of the bond market
Municipal bonds are already beloved by high-income investors, but those seeking additional yield and beefier returns are reaching for a little more risk. The high-yield...
JPMorgan’s top biopharma picks for 2025
JPMorgan has an updated set of biopharma names that could see upside this year, after a hot and cold period for some companies in the...
